Despite the intermediate group expressing significantly higher levels of the anti-inflammatory cytokines TGFβ and IL-10, no significant change in percentage of TIM-3 positivity was observed between all three subgroups of monocytes from glioma patients versus healthy controls [104]. The gene discussed is HAVCR2; the disease is glioma.